Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and ...
Breast cancer has been identified as a disease that claims the lives of three Sri Lankan women every day. Accordingly, the ...
Pancreatic Cancer Awareness Month highlights the growing concern in Washington as the disease claims lives rapidly.
The massive study, which was conducted in Sweden and tracked more than 2 million teenage girls and women under age 50 for more than a decade, found that hormonal contraception remains safe overall, ...
AZoLifeSciences on MSN
Researchers Discover Molecular Switch That Helps Breast Cancer Cells Survive Stress
Cells are regularly faced with environmental stresses that may damage or destroy them. To survive, they quickly adjust their ...
Zacks Investment Research on MSN
RHHBY Reports Positive Phase III Data on Breast Cancer Drug
Roche RHHBY announced positive data from the late-stage lidERA Breast Cancer study on pipeline candidate giredestrant.
Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...
Roche claimed the results make its drug giredestrant the first of its kind, a so-called oral SERD, to show a benefit in the ...
The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...
Jayne McHugh Gibson, a Pacific volleyball legend and Olympian, died after a brief fight against an aggressive form of cancer ...
Op-Ed: A human connection can be a meaningful part of healing and reclaiming your well-being after cancer.
OLMA stock surged 197% after Roche’s SERD breakthrough, signaling investor conviction in the future of ER-positive breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results